Gain Therapeutics, Inc. (GANX)
1.82
+0.02
(+1.11%)
USD |
NASDAQ |
May 13, 13:28
Gain Therapeutics EPS Diluted (Quarterly) : -0.1328 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Agenus, Inc. | 1.023 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
| Anika Therapeutics, Inc. | -0.3737 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.609M |
| Total Expenses (Quarterly) | 5.609M |
| Enterprise Value | 60.61M |
| Earnings Yield | -32.34% |
| Normalized Earnings Yield | -32.34 |